Merck & Co., Inc. Share Price & Technical Analysis

MRK · $114.7 (-0.82%)

Healthcare / Drug Manufacturers - General

AI Score 28 · Bearish

$114.7

-0.82%

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, an

Price chart

Seasonality

Jun has 2 positive and 3 negative years (last 5 years shown)

-2% return in Jun, 2% avg return in past 3 year Jun month.

8% return in 2026, -2% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
265%12%-3%-10%6%-2%8%
25-1%-6%-2%-5%-9%3%-1%8%-1%1%22%1%9%
2411%3%4%-2%-2%-2%-10%5%-4%-10%0%-2%-10%
23-3%-1%0%9%-5%4%-7%-1%-6%0%-1%6%-3%
226%-7%7%8%4%-1%-2%-4%1%17%9%1%39%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 28/100

Bearish · Emerging · Neutral

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$286.13B

P/E ratio

32.63

52W high

$125.1

52W low

$76.66

Volume

60,12,833

Beta

0.20

Related stocks in Healthcare

Frequently asked questions

What is Merck & Co., Inc. share price today?
Merck & Co., Inc. (MRK) last traded around $114.7 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does MRK have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for MRK. Download the app for real-time alerts.
How can I analyze Merck & Co., Inc. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro